2. Campbell EG, Gruen RL, Mountford J, et al. A national survey of physician-industry relationships. N Engl J Med 2007; 356: 1742–1750.
3. Moses H 3rd, Dorsey ER, Matheson DH, et al. Financial anatomy of biomedical research. JAMA 2005; 294: 1333–1342.
4. Perlis RH, Perlis CS, Wu Y, et al. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 2005; 162: 1957–1960.
5. Schulman KA, Seils DM, Timbie JW, et al. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med 2002;347:1335–1341.
6. Ehringhaus S, Korn D. Principles for protecting integrity in the conduct and reporting of clinical trials. Washington, DC: Association of American Medical Colleges. Available: http://www.aamc.org/research/clinicaltrialsreporting/clinicaltrialsreporting.pdf. Accessed 2008 Mar 10.
7. Weinfurt KP, Dinan MA, Allsbrook JS, et al. Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Acad Med 2006;81:113–118.
8. Weinfurt KP, Friedman JY, Allsbrook JS, et al. Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure. J Gen Intern Med 2006; 21: 901–906.
9. Weinfurt KP, Allsbrook JS, Friedman JY, Dinan MA, Hall MA, et al. Developing model language for disclosing financial interests to potential clinical research participants. IRB 2007;29:1–5.
10. Davidoff F, DeAngelis CD, Drazen JM, et al. Sponsorship, authorship, and accountability. JAMA 2001; 286: 1232–1234.
11. Krimsky S. Journal policies on conflict of interest: If this is the therapy, what’s the disease? Psychother Psychosom 2001;70:115–117.
12. Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics 2001; 7: 205–218.
13. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (Updated February 2006). Available: http://www.icmje.org/. Accessed 2007 Jul 25.
14. World Association of Medical Editors. WAME recommendations on publication ethics policies for medical journals. Available: http://www.wame.org/resources/ethics-resources/publication-ethics-policies-for-medical-journals/. Accessed 2007 Jul 25.
15. Council of Science Editors. CSE’s white paper on promoting integrity in scientific journal publications. Available: http://www.councilscienceeditors.org/editorial_policies/white_paper.cfm . Accessed 2007 Jul 25.
16. Cooper RJ, Gupta M, Wilkes MS, et al. Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals. J Gen Intern Med 2006;21:1248–1252.
17. DeAngelis CD. The influence of money on medical science. JAMA 2006;296:996–998.
18. Angell M, Kassirer JP. Editorials and conflicts of interest. N Engl J Med 1996;335:1055–1056.
19. Krimsky S. Science in the private interest: Has the lure of profits corrupted biomedical research? New York: Rowman Littlefield; 2003.
20. Gross CP, Gupta AR, Krumholz HM. Disclosure of financial competing interests in randomised controlled trials: cross sectional review. BMJ 2003; 326: 526–527.
21. Tanner L. Study renews conflict-of-interest debate [wire service release]. Associated Press. July 24, 2007.
22. Hussain A, Smith R. Declaring financial competing interests: survey of five general medical journals. BMJ 2001; 323: 263–264.
23. Riechelmann RP, Wang L, O’Carroll A, et al. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. J Clin Oncol 2007; 25: 4642–4647.
24. Shuchman M. Debating the risks of drug-eluting stents. N Engl J Med 2007;356:325–328.
25. Hensley S. Medicare gives boost to stents that are coated. Wall Street Journal. August 1, 2002: D3.
26. Cohen R. Stent-hearing waivers stir FDA ethics debate. The Star-Ledger (Newark, NJ). December 5, 2006: 25.
27. Journal Citation Reports: 2006 JCR Science Edition. Philadelphia: Thomson Scientific; 2007. Available: http://www.isiknowledge.com/. Accessed 2007 Mar 10.
28. International Committee of Medical Journal Editors. Journals that have Requested Inclusion on the List of Publications that follow the ICMJE’s Uniform Requirements For Manuscripts Submitted to Biomedical Journals. Available: http://www.icmje.org/jrnlist.html. Accessed 2007 Jul 25.
29. Krimsky S, Rothenberg LS. Financial interest and its disclosure in scientific publications. JAMA 1998; 280: 225–226.
30. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA 2005; 294: 110–111.
31. Neill US, Thompson CB, Feldmann M, et al. A new JCI conflict-of-interest policy. J Clin Invest 2007; 117: 506–508.
32. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment—correction. JAMA 2006; 296: 170.
33. Armstrong D. Research digest to ease access to author disclosures. Wall Street Journal. June 8, 2007: B6.
34. Harris G. Cigarette company paid for lung cancer study. New York Times. March 26, 2008: A1.
35. Henschke CI, Yankelevitz DF. Unreported financial disclosures. JAMA 2008. In press.
36. Schwartz RS, Curfman GD, Morrissey S, et al. Full disclosure and the funding of biomedical research. N Engl J Med 2008. In press.
37. Shah JY (2005) The automatic pursuit and management of goals. Curr Dir Psychol Sci 2005; 14: 10–13.
38. Nisbett RE, Wilson TD. Telling more than we can know: verbal reports on mental processes. Psychol Rev 1977; 84: 251–259.
39. AAMC Task Force on Financial Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research. Acad Med 2003; 78: 225–236.
40. Chaudhry S, Schroter S, Smith R, et al. Does declaration of competing interests affect readers’ perceptions? A randomised trial. BMJ 2002; 325: 1391–1392.
41. Schroter S, Morris J, Chaudhry S, et al. Does the type of competing interest statement affect readers’ perceptions of the credibility of research? Randomised trial. BMJ 2004; 328: 742–743.
42. Cain DM, Loewenstein G, Moore DA. Coming clean but playing dirtier: the shortcomings of disclosure as a solution to conflicts of interest. In: Moore DA, Cain DM, Lowenstein G, Bazerman MH, editors. Conflicts of interest. Cambridge: Cambridge University Press. pp. 105–125, 2005.
43. Cain DM, Loewenstein G, Moore DA. The dirt on coming clean: perverse effects of disclosing conflicts of interest. J Legal Stud 2005; 34: 1–25.
44. Hampson LA, Agrawal M, Joffe S, et al. Patients’ views on financial conflicts of interest in cancer research trials. N Engl J Med 2006; 355: 2330–2337.
45. Kim SY, Millard RW, Nisbet P, et al. Potential research participants’ views regarding researcher and institutional financial conflicts of interest. J Med Ethics 2004; 30: 73–79.